Vesicare 5mg & 10mg Tablet
PDF Leaflet Revision Date: 2 June 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of overactive bladder syndrome.
Dosage (summary)
5 mg once daily, may increase to 10 mg once daily.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors (e.g., ketoconazole)
- Anticholinergic medications
Contraindications
- Hypersensitivity
- Urinary retention
- Narrow angle glaucoma
- Myasthenia gravis
- Toxic megacolon
- Severe renal impairment
- Severe hepatic impairment
Common side effects
- Dry mouth
- Constipation
- Dizziness
- Blurred vision
Counselling Points
- Take with or without food.
- May cause blurred vision; caution with driving.
- Report any signs of allergic reactions.
Serious warnings
- Risk of urinary retention
- QT prolongation
- Angioedema
Important Disclaimer
The Vesicare 5mg & 10mg Tablet professional information leaflet below is the property of Astellas Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
